In areas like drug-resistant cancers and viral diseases, the demand for innovative and right
solutions has never been more urgent. Understanding the need, several players have
entered the industry, but one company stands out as a pioneering industry-first biological
therapeutics company for viruses and cancers—Creative BioTherapeutics, led by Anita
Davidson.
The company’s vision is to build non-toxic, biologic therapies to enhance patients’ lives
with mid- to late-stage diseases, including viruses and cancer. CBT begins where others
fail—it is committed to providing the safest options possible for solving treatment vacuums
for patients with some hope.
Anita Davidson: The Leading Lady
In the evolving era of biotech, Anita Davidson is a trailblazer whose determination and
unwavering commitment have made a notable impact on the global healthcare realm. As a
seasoned professional in physical therapy and biotechnology, Anita Davidson is bringing
breakthrough solutions. Her journey epitomizes the essence of purpose-driven leadership
and visionary stewardship in healthcare. Revolutionary indeed, both Anita Davidson and
her Biotech company CBT, are proudly leading the realm by introducing breakthrough
solutions in cancer treatment.
As the CEO of Creative BioTherapeutics, she is a pioneer. Her academic pursuit mirrors
her global, innovative outlook. She holds a Doctor of Physical Therapy degree from
Rosalind Franklin University and a BS in Physical Therapy from Indiana University. But it
was never theory alone that inspired her. From the outset, Anita was drawn to
environments that support and empower people. She has a robust background in growing
healthcare businesses like her own Creative Rehab clinic. What sets her apart is not
achievements, but credibility earned through execution, dedication, and consistency to
ensure maximum benefits to patients.
Creative BioTherapeutics: An Insight
Creative BioTherapeutics is an emerging biotech firm, actively working on the R&D of a
biological therapeutics platform for viruses and cancers. The company aims to build on the
extensive pharmaceutical experience and the commercialization/business experience of
Anita Davidson and the co-founder.
As of now, CBT is working on the viral mechanism of COVID-19 and the requirement for
effective and safe treatments for late-stage diseases, such as late-stage COVID-19 and
variants of concern. According to experts, “the COVID-19 pandemic is behind us.” People
with compromised immune systems or suffering from comorbidities like cancer, obesity,
and diabetes are at a higher risk for continued disease.
CBT’s advanced technology attacks these health problems for patients with low immune
response. Here, vaccines and other therapies stop working, but CBT’s innovation works.
Under Anita Davidson’s dynamic guidance, CBT is continuously striving to deliver
innovative therapies for patients with the most unmet medical needs where other
therapies are not effective anymore.
Turning Point: The Key Inspiration
There was a deeply emotional motivation that pushed Anita’s career. She keeps the
pictures of patients who have lost their lives but could have benefited from the therapies
CBT holds today.
One 15-year-old patient, named Parker, passed away just days before his 16th birthday.
Such personal stories fuel the inception of Creative BioTherapeutics and push its mission to
deliver therapeutics to bring remarkable change outcomes for patients having no options
left.
The Obstacles Along the Way
When asked about her biggest challenge, Anita says that from the beginning to every step
of the journey, whether designing a class or founding a biotech, her biggest enemy has been
fear. While starting anything new brings fear, women leaders must go through the fear of
being different, of failure, and of embarrassment; this self-doubt has pushed many women
leaders back. While numerous women leaders have sidestepped the fear and operated
aggressively to compete with their male counterparts.
One of the common challenges leaders face is losing the elements that make them unique
due to fear, regardless of the business. Here, Anita has realized that running from fear is not
the solution. Instead, try to identify your fear and embrace it to make a difference. Anita
highlights that she has been lucky to have a supportive partner, her husband, who has
encouraged her beyond her fears and encourages her to thrive in all scales of new
ventures.
Jewels in the Crown
Anita Davidson and her venture, Creative BioTherapeutics, have been honored with
multiple awards and recognitions. Some significant features include their published story
in the USA Today, highlighting their journey as pioneers in cancer therapy with an
innovative approach and breakthrough solutions.
They were also featured in the International Business Times. The reputed organization Life
Science Review recognized Creative BioTherapeutics as the Cancer Drug Resistance
Company of 2025. The leading lady, Anita Davidson, has been honored by a Marquis Who’s
Who press release, the Xraised Podcast, and Close Up TV & Radio. She also received the
Upcoming Business Leadership Excellence Award at the CXO 2.0 Conference.
Some other recognitions include being named as one of the Top 10 Innovative & Disruptive
Founders by Kevin Harrington (Shark Tank) in UK Entrepreneur Magazine and being
featured among the “10 Best Companies to Watch in 2025” by CEO Viewpoint.
In the transformative journey of Anita, each endeavor presents a narrative of resilience,
innovation, and continuous hard work. From humble beginnings to global recognition and
emerging as an urgent frontier in healthcare, Anita’s trajectory serves as a testament to the
transformative power of a visionary approach and dynamic leadership.